MORGAN STANLEY PLC/CALL/AMGEN/290/0.1/20.12.24 Share Price

Warrant

DE000MB16YL1

Market Closed - Börse Stuttgart 19:31:34 05/07/2024 BST
3.62 EUR +3.13% Intraday chart for MORGAN STANLEY PLC/CALL/AMGEN/290/0.1/20.12.24
Current month-3.72%
1 month-0.28%
Date Price Change
05/07/24 3.62 +3.13%
04/07/24 3.51 -0.57%
03/07/24 3.53 -6.61%
02/07/24 3.78 +1.07%
01/07/24 3.74 -0.53%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 07:31 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying AMGEN INC.
Issuer Morgan Stanley
WKN MB16YL
ISINDE000MB16YL1
Date issued 05/12/2022
Strike 290 $
Maturity 20/12/2024 (167 Days)
Parity 10 : 1
Emission price 4.91
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.03
Lowest since issue 0.38
Delta0.67x
Omega 5.252
Premium6.06x
Gearing7.82x
Moneyness 1.072
Difference Strike -20.88 $
Difference Strike %-7.20%
Spread 0.03
Spread %0.82%
Theoretical value 3.665
Implied Volatility 33.01 %
Total Loss Probability 40.30 %
Intrinsic value 1.926
Present value 1.739
Break even 329.73 €
Theta-0.05x
Vega0.07x
Rho0.07x

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.
Sector
-
More about the company

Ratings for Amgen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Amgen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9 USD
Average target price
316.4 USD
Spread / Average Target
+1.79%
Consensus